{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T21:18:52Z","timestamp":1794950332611,"version":"4.9.1"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82271847"],"award-info":[{"award-number":["No.82271847"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-025-02175-5","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:13:16Z","timestamp":1769523196000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Nanozyme-based therapies for inflammatory immune disorders: opportunities and challenges"],"prefix":"10.1007","volume":"75","author":[{"given":"Wenqian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaozhe","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongfen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"2175_CR1","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1056\/NEJMra1909094","volume":"385","author":"G Schett","year":"2021","unstructured":"Schett G, McInnes IB, Neurath MF. Reframing immune-mediated inflammatory diseases through signature cytokine hubs. N Engl J Med. 2021;385:628\u201339. https:\/\/doi.org\/10.1056\/NEJMra1909094.","journal-title":"N Engl J Med"},{"key":"2175_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2023.105627","volume":"91","author":"A Mathian","year":"2024","unstructured":"Mathian A, Felten R, Alarcon-Riquelme ME, Psarras A, Mertz P, Chasset F, et al. Type 1 interferons: a target for immune-mediated inflammatory diseases (IMIDs). Joint Bone Spine. 2024;91:105627. https:\/\/doi.org\/10.1016\/j.jbspin.2023.105627.","journal-title":"Joint Bone Spine"},{"key":"2175_CR3","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s41577-021-00603-1","volume":"21","author":"IB McInnes","year":"2021","unstructured":"McInnes IB, Gravallese EM. Immune-mediated inflammatory disease therapeutics: past, present and future. Nat Rev Immunol. 2021;21:680\u20136. https:\/\/doi.org\/10.1038\/s41577-021-00603-1.","journal-title":"Nat Rev Immunol"},{"key":"2175_CR4","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/med.21330","volume":"35","author":"Y Lei","year":"2015","unstructured":"Lei Y, Wang K, Deng L, Chen Y, Nice EC, Huang C. Redox regulation of inflammation: old elements, a new story. Med Res Rev. 2015;35:306\u201340. https:\/\/doi.org\/10.1002\/med.21330.","journal-title":"Med Res Rev"},{"key":"2175_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1217165","volume":"14","author":"DK Sahoo","year":"2023","unstructured":"Sahoo DK, Heilmann RM, Paital B, Patel A, Yadav VK, Wong D, et al. Oxidative stress, hormones, and effects of natural antioxidants on intestinal inflammation in inflammatory bowel disease. Front Endocrinol. 2023;14:1217165. https:\/\/doi.org\/10.3389\/fendo.2023.1217165.","journal-title":"Front Endocrinol"},{"key":"2175_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10753-020-01338-2","volume":"44","author":"Z Xie","year":"2021","unstructured":"Xie Z, Hou H, Luo D, An R, Zhao Y, Qiu C. ROS-dependent lipid peroxidation and reliant antioxidant ferroptosis-suppressor-protein 1 in rheumatoid arthritis: a covert clue for potential therapy. Inflammation. 2021;44:35\u201347. https:\/\/doi.org\/10.1007\/s10753-020-01338-2.","journal-title":"Inflammation"},{"key":"2175_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020723","author":"P W\u00f3jcik","year":"2021","unstructured":"W\u00f3jcik P, G\u0119gotek A, \u017darkovi\u0107 N, Skrzydlewska E. Oxidative stress and lipid mediators modulate immune cell functions in autoimmune diseases. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22020723.","journal-title":"Int J Mol Sci"},{"key":"2175_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012137","author":"A Wro\u0144ski","year":"2022","unstructured":"Wro\u0144ski A, W\u00f3jcik P. Impact of ROS-dependent lipid metabolism on psoriasis pathophysiology. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232012137.","journal-title":"Int J Mol Sci"},{"key":"2175_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cbi.2017.12.024","volume":"281","author":"AR Phull","year":"2018","unstructured":"Phull AR, Nasir B, Haq IU, Kim SJ. Oxidative stress, consequences and ROS mediated cellular signaling in rheumatoid arthritis. Chem Biol Interact. 2018;281:121\u201336. https:\/\/doi.org\/10.1016\/j.cbi.2017.12.024.","journal-title":"Chem Biol Interact"},{"key":"2175_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.129374","author":"S Singh","year":"2024","unstructured":"Singh S. Antioxidant nanozymes as next-generation therapeutics to free radical-mediated inflammatory diseases: a comprehensive review. Int J Biol Macromol. 2024. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.129374.","journal-title":"Int J Biol Macromol"},{"key":"2175_CR11","doi-asserted-by":"publisher","DOI":"10.1039\/d1tb00720c","author":"H Zhao","year":"2021","unstructured":"Zhao H, Zhang R, Yan X, Fan K. Superoxide dismutase nanozymes: an emerging star for anti-oxidation. J Mater Chem B. 2021. https:\/\/doi.org\/10.1039\/d1tb00720c.","journal-title":"J Mater Chem B"},{"key":"2175_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/nu13020282","author":"A Jurcau","year":"2021","unstructured":"Jurcau A. The role of natural antioxidants in the prevention of dementia-where do we stand and future perspectives. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13020282.","journal-title":"Nutrients"},{"key":"2175_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.nxmate.2024.100401","author":"F Corsi","year":"2024","unstructured":"Corsi F, Pelliccia A, Deidda Tarquini G, Urbani M, Failla CM, Traversa E, et al. Topical treatment of skin diseases with bioactive inorganic nanomaterials: beyond drug delivery. Next Mater. 2024. https:\/\/doi.org\/10.1016\/j.nxmate.2024.100401.","journal-title":"Next Mater"},{"key":"2175_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202512409","author":"VG Panferov","year":"2025","unstructured":"Panferov VG, Zhang X, Wong KY, Lee JH, Liu J. Biomedical applications of nanozymes: an enzymology perspective. Angew Chem Int Ed. 2025. https:\/\/doi.org\/10.1002\/anie.202512409.","journal-title":"Angew Chem Int Ed"},{"key":"2175_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202407816","author":"N Tagaras","year":"2024","unstructured":"Tagaras N, Song H, Sahar S, Tong W, Mao Z, Buerki-Thurnherr T. Safety landscape of therapeutic nanozymes and future research directions. Adv Sci (Weinh). 2024. https:\/\/doi.org\/10.1002\/advs.202407816.","journal-title":"Adv Sci (Weinh)"},{"key":"2175_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s44222-024-00205-1","author":"R Zhang","year":"2024","unstructured":"Zhang R, Jiang B, Fan K, Gao L, Yan X. Designing nanozymes for in vivo applications. Nat Rev Bioeng. 2024. https:\/\/doi.org\/10.1038\/s44222-024-00205-1.","journal-title":"Nat Rev Bioeng"},{"key":"2175_CR17","doi-asserted-by":"publisher","first-page":"9442","DOI":"10.1021\/acs.nanolett.1c02702","volume":"21","author":"Y Liu","year":"2021","unstructured":"Liu Y, Huang Y, Kim D, Ren Z, Oh MJ, Cormode DP, et al. Ferumoxytol nanoparticles target biofilms causing tooth decay in the human mouth. Nano Lett. 2021;21:9442\u20139. https:\/\/doi.org\/10.1021\/acs.nanolett.1c02702.","journal-title":"Nano Lett"},{"key":"2175_CR18","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nnano.2007.260","volume":"2","author":"L Gao","year":"2007","unstructured":"Gao L, Zhuang J, Nie L, Zhang J, Zhang Y, Gu N, et al. Intrinsic peroxidase-like activity of ferromagnetic nanoparticles. Nat Nanotechnol. 2007;2:577\u201383. https:\/\/doi.org\/10.1038\/nnano.2007.260.","journal-title":"Nat Nanotechnol"},{"key":"2175_CR19","doi-asserted-by":"publisher","DOI":"10.1039\/c3cs35486e","author":"H Wei","year":"2013","unstructured":"Wei H, Wang E. Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes. Chem Soc Rev. 2013. https:\/\/doi.org\/10.1039\/c3cs35486e.","journal-title":"Chem Soc Rev"},{"key":"2175_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.partic.2022.08.009","author":"A Lin","year":"2022","unstructured":"Lin A, Liu S, Wei H. Nanozymes for biomedical applications in orthopaedics. Particuology. 2022. https:\/\/doi.org\/10.1016\/j.partic.2022.08.009.","journal-title":"Particuology"},{"key":"2175_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02844-3","author":"X Gao","year":"2024","unstructured":"Gao X, Zhang J, Gong Y, Yan L. The biomedical applications of nanozymes in orthopaedics based on regulating reactive oxygen species. J Nanobiotechnology. 2024. https:\/\/doi.org\/10.1186\/s12951-024-02844-3.","journal-title":"J Nanobiotechnology"},{"key":"2175_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202211210","author":"J Sheng","year":"2023","unstructured":"Sheng J, Wu Y, Ding H, Feng K, Shen Y, Zhang Y, et al. Multienzyme-like nanozymes: regulation, rational design, and application. Adv Mater. 2023. https:\/\/doi.org\/10.1002\/adma.202211210.","journal-title":"Adv Mater"},{"key":"2175_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.mattod.2020.08.020","author":"Z Wang","year":"2020","unstructured":"Wang Z, Zhang R, Yan X, Fan K. Structure and activity of nanozymes: inspirations for de novo design of nanozymes. Mater Today. 2020. https:\/\/doi.org\/10.1016\/j.mattod.2020.08.020.","journal-title":"Mater Today"},{"key":"2175_CR24","doi-asserted-by":"publisher","DOI":"10.1039\/c8cs00457a","author":"J Wu","year":"2018","unstructured":"Wu J, Wang X, Wang Q, Lou Z, Li S, Zhu Y, et al. Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)\u2020. Chem Soc Rev. 2018. https:\/\/doi.org\/10.1039\/c8cs00457a.","journal-title":"Chem Soc Rev"},{"key":"2175_CR25","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.122.000719","author":"G Sharma","year":"2023","unstructured":"Sharma G, Chatterjee S, Chakraborty C, Kim J-C. Advances in nanozymes as a paradigm for viral diagnostics and therapy. Pharmacol Rev. 2023. https:\/\/doi.org\/10.1124\/pharmrev.122.000719.","journal-title":"Pharmacol Rev"},{"key":"2175_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202203400","author":"D Xu","year":"2022","unstructured":"Xu D, Wu L, Yao H, Zhao L. Catalase-like nanozymes: classification, catalytic mechanisms, and their applications. Small. 2022. https:\/\/doi.org\/10.1002\/smll.202203400.","journal-title":"Small"},{"key":"2175_CR27","doi-asserted-by":"publisher","DOI":"10.1039\/d2bm01915a","author":"Y Lai","year":"2023","unstructured":"Lai Y, Wang J, Yue N, Zhang Q, Wu J, Qi W, et al. Glutathione peroxidase-like nanozymes: mechanism, classification, and bioapplication. Biomater Sci. 2023. https:\/\/doi.org\/10.1039\/d2bm01915a.","journal-title":"Biomater Sci"},{"key":"2175_CR28","doi-asserted-by":"publisher","DOI":"10.1039\/c0nr00875c","author":"I Celardo","year":"2011","unstructured":"Celardo I, Pedersen JZ, Traversa E, Ghibelli L. Pharmacological potential of cerium oxide nanoparticles. Nanoscale. 2011. https:\/\/doi.org\/10.1039\/c0nr00875c.","journal-title":"Nanoscale"},{"key":"2175_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202401963","author":"X Yang","year":"2024","unstructured":"Yang X, Tan M, Guo J, Xiang J, Yin F, Deng J, et al. PdZn\/CoSA-NC nanozymes with highly efficient SOD\/CAT activities for treatment of osteoarthritis via regulating immune microenvironment. Adv Funct Mater. 2024. https:\/\/doi.org\/10.1002\/adfm.202401963.","journal-title":"Adv Funct Mater"},{"key":"2175_CR30","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.2c06981","author":"W Wang","year":"2022","unstructured":"Wang W, Zheng J, Zhou H, Liu Q, Jia L, Zhang X, et al. Polydopamine-based nanocomposite as a biomimetic antioxidant with a variety of enzymatic activities for Parkinson\u2019s disease. ACS Appl Mater Interfaces. 2022. https:\/\/doi.org\/10.1021\/acsami.2c06981.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2175_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201600868","author":"Y Huang","year":"2016","unstructured":"Huang Y, Liu Z, Liu C, Ju E, Zhang Y, Ren J, et al. Self\u2010assembly of multi\u2010nanozymes to mimic an intracellular antioxidant defense system. Angew Chem Int Ed. 2016. https:\/\/doi.org\/10.1002\/anie.201600868.","journal-title":"Angew Chem Int Ed"},{"key":"2175_CR32","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.3c05351","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Xu J, Lin Q, Song J, Sheng M, Lee J, et al. pH-activated scallop-type nanoenzymes for oxidative stress amplification and photothermal enhancement of antibacterial and antibiofilm effect. ACS Appl Mater Interfaces. 2023. https:\/\/doi.org\/10.1021\/acsami.3c05351.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2175_CR33","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c07930","author":"J Xiong","year":"2022","unstructured":"Xiong J, Cao Y, Zhao H, Chen J, Cai X, Li X, et al. Cooperative antibacterial enzyme-Ag-polymer nanocomposites. ACS Nano. 2022. https:\/\/doi.org\/10.1021\/acsnano.2c07930.","journal-title":"ACS Nano"},{"key":"2175_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202305979","author":"W Qiao","year":"2024","unstructured":"Qiao W, Chen J, Zhou H, Hu C, Dalangood S, Li H, et al. A single-atom manganese nanozyme Mn-N\/C promotes anti-tumor immune response via eliciting type I interferon signaling. Adv Sci. 2024. https:\/\/doi.org\/10.1002\/advs.202305979.","journal-title":"Adv Sci"},{"key":"2175_CR35","doi-asserted-by":"publisher","DOI":"10.1039\/d3nr05592b","author":"Y Ye","year":"2024","unstructured":"Ye Y, Zou J, Wu W, Wang Z, Wen S, Liang Z, et al. Advanced nanozymes possess peroxidase-like catalytic activities in biomedical and antibacterial fields: review and progress. Nanoscale. 2024. https:\/\/doi.org\/10.1039\/d3nr05592b.","journal-title":"Nanoscale"},{"key":"2175_CR36","doi-asserted-by":"publisher","DOI":"10.1039\/d4tb00769g","author":"X Xu","year":"2024","unstructured":"Xu X, Zhang Y, Meng C, Zheng W, Wang L, Zhao C, et al. Nanozymes in cancer immunotherapy: metabolic disruption and therapeutic synergy. J Mater Chem B. 2024. https:\/\/doi.org\/10.1039\/d4tb00769g.","journal-title":"J Mater Chem B"},{"key":"2175_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-00395-4","author":"M Lv","year":"2020","unstructured":"Lv M, Chen M, Zhang R, Zhang W, Wang C, Zhang Y, et al. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy. Cell Res. 2020. https:\/\/doi.org\/10.1038\/s41422-020-00395-4.","journal-title":"Cell Res"},{"key":"2175_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-019-03667-9","volume":"467","author":"S Yang","year":"2020","unstructured":"Yang S, Lian G. ROS and diseases: role in metabolism and energy supply. Mol Cell Biochem. 2020;467:1\u201312. https:\/\/doi.org\/10.1007\/s11010-019-03667-9.","journal-title":"Mol Cell Biochem"},{"key":"2175_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.tplants.2016.08.002","volume":"22","author":"R Mittler","year":"2017","unstructured":"Mittler R. ROS are good. Trends Plant Sci. 2017;22:11\u20139. https:\/\/doi.org\/10.1016\/j.tplants.2016.08.002.","journal-title":"Trends Plant Sci"},{"key":"2175_CR40","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","volume":"22","author":"EC Cheung","year":"2022","unstructured":"Cheung EC, Vousden KH. The role of ROS in tumour development and progression. Nat Rev Cancer. 2022;22:280\u201397. https:\/\/doi.org\/10.1038\/s41568-021-00435-0.","journal-title":"Nat Rev Cancer"},{"key":"2175_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2018.101084","volume":"25","author":"US Srinivas","year":"2019","unstructured":"Srinivas US, Tan BWQ, Vellayappan BA, Jeyasekharan AD. ROS and the DNA damage response in cancer. Redox Biol. 2019;25:101084. https:\/\/doi.org\/10.1016\/j.redox.2018.101084.","journal-title":"Redox Biol"},{"key":"2175_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4535194","volume":"2017","author":"T Tian","year":"2017","unstructured":"Tian T, Wang Z, Zhang J. Pathomechanisms of oxidative stress in inflammatory bowel disease and potential antioxidant therapies. Oxid Med Cell Longev. 2017;2017:4535194. https:\/\/doi.org\/10.1155\/2017\/4535194.","journal-title":"Oxid Med Cell Longev"},{"key":"2175_CR43","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5793817","volume":"2020","author":"MJ Tavassolifar","year":"2020","unstructured":"Tavassolifar MJ, Vodjgani M, Salehi Z, Izad M. The influence of reactive oxygen species in the immune system and pathogenesis of multiple sclerosis. Autoimmune Dis. 2020;2020:5793817. https:\/\/doi.org\/10.1155\/2020\/5793817.","journal-title":"Autoimmune Dis"},{"key":"2175_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2021.101026","volume":"85","author":"C Michaeloudes","year":"2022","unstructured":"Michaeloudes C, Abubakar-Waziri H, Lakhdar R, Raby K, Dixey P, Adcock IM, et al. Molecular mechanisms of oxidative stress in asthma. Mol Aspects Med. 2022;85:101026. https:\/\/doi.org\/10.1016\/j.mam.2021.101026.","journal-title":"Mol Aspects Med"},{"key":"2175_CR45","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.ajps.2022.10.005","volume":"17","author":"J Hu","year":"2022","unstructured":"Hu J, Bian Q, Ma X, Xu Y, Gao J. A double-edged sword: ROS related therapies in the treatment of psoriasis. Asian J Pharm Sci. 2022;17:798\u2013816. https:\/\/doi.org\/10.1016\/j.ajps.2022.10.005.","journal-title":"Asian J Pharm Sci"},{"key":"2175_CR46","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.expneurol.2015.11.010","volume":"277","author":"K Ohl","year":"2016","unstructured":"Ohl K, Tenbrock K, Kipp M. Oxidative stress in multiple sclerosis: central and peripheral mode of action. Exp Neurol. 2016;277:58\u201367. https:\/\/doi.org\/10.1016\/j.expneurol.2015.11.010.","journal-title":"Exp Neurol"},{"key":"2175_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189175","volume":"1879","author":"A Chen","year":"2024","unstructured":"Chen A, Huang H, Fang S, Hang Q. ROS: a \u201cbooster\u201d for chronic inflammation and tumor metastasis. Biochim Biophys Acta Rev Cancer. 2024;1879:189175. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189175.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2175_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11061153","author":"X Wang","year":"2022","unstructured":"Wang X, Fan D, Cao X, Ye Q, Wang Q, Zhang M, et al. The role of reactive oxygen species in the rheumatoid arthritis-associated synovial microenvironment. Antioxidants. 2022. https:\/\/doi.org\/10.3390\/antiox11061153.","journal-title":"Antioxidants"},{"key":"2175_CR49","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","volume":"20","author":"YZ Zhang","year":"2014","unstructured":"Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 2014;20:91\u20139. https:\/\/doi.org\/10.3748\/wjg.v20.i1.91.","journal-title":"World J Gastroenterol"},{"key":"2175_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2023.1089775","author":"Y Chang","year":"2023","unstructured":"Chang Y, Wu X, Lu S, Du J, Long Y, Zhu Y, et al. Engineered procyanidin-Fe nanoparticle alleviates intestinal inflammation through scavenging ROS and altering gut microbiome in colitis mice. Front Chem. 2023. https:\/\/doi.org\/10.3389\/fchem.2023.1089775.","journal-title":"Front Chem"},{"key":"2175_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122822","author":"Y Huang","year":"2024","unstructured":"Huang Y, Xu J, Sun G, Cheng X, An Y, Yao X, et al. Enteric-coated cerium dioxide nanoparticles for effective inflammatory bowel disease treatment by regulating the redox balance and gut microbiome. Biomaterials. 2024. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122822.","journal-title":"Biomaterials"},{"key":"2175_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202302576","author":"K Jiang","year":"2023","unstructured":"Jiang K, Cao X, Wu H, Xu Y, Liu L, Qian H, et al. 2D nanozymes modulate gut microbiota and T-cell differentiation for inflammatory bowel disease management. Adv Healthc Mater. 2023. https:\/\/doi.org\/10.1002\/adhm.202302576.","journal-title":"Adv Healthc Mater"},{"key":"2175_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01770-0","author":"Y Cao","year":"2023","unstructured":"Cao Y, Cheng K, Yang M, Deng Z, Ma Y, Yan X, et al. Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory\/anti-fibrotic therapy of inflammatory bowel disease. J Nanobiotechnol. 2023. https:\/\/doi.org\/10.1186\/s12951-023-01770-0.","journal-title":"J Nanobiotechnol"},{"key":"2175_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202100081","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Cheng C, Yao J, Yu Y, Liu Y, Zhang H, et al. Mn3O4 nanozyme for inflammatory bowel disease therapy. Adv Ther. 2021. https:\/\/doi.org\/10.1002\/adtp.202100081.","journal-title":"Adv Ther"},{"key":"2175_CR55","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.8b10345","author":"J Zhao","year":"2018","unstructured":"Zhao J, Cai X, Gao W, Zhang L, Zou D, Zheng Y, et al. Prussian blue nanozyme with multienzyme activity reduces colitis in mice. ACS Appl Mater Interfaces. 2018. https:\/\/doi.org\/10.1021\/acsami.8b10345.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2175_CR56","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.4c11100","author":"Y Ren","year":"2024","unstructured":"Ren Y, Chen Q, Lu Z, Su G, Wu C, Rao H, et al. MnNi@PVP nanoenzyme based on regulating inflammation and immune homeostasis for the therapy of inflammatory bowel disease. ACS Appl Mater Interfaces. 2024. https:\/\/doi.org\/10.1021\/acsami.4c11100.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2175_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202101618","author":"N Zhao","year":"2021","unstructured":"Zhao N, Yang F-E, Zhao C-Y, Lv S-W, Wang J, Liu J-M, et al. Construction of pH-dependent nanozymes with oxygen vacancies as the high-efficient reactive oxygen species scavenger for oral-administrated anti-inflammatory therapy. Adv Healthc Mater. 2021. https:\/\/doi.org\/10.1002\/adhm.202101618.","journal-title":"Adv Healthc Mater"},{"key":"2175_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202004692","author":"S Zhao","year":"2020","unstructured":"Zhao S, Li Y, Liu Q, Li S, Cheng Y, Cheng C, et al. An orally administered CeO2@Montmorillonite nanozyme targets inflammation for inflammatory bowel disease therapy. Adv Funct Mater. 2020. https:\/\/doi.org\/10.1002\/adfm.202004692.","journal-title":"Adv Funct Mater"},{"key":"2175_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01319-7","author":"F Zeng","year":"2022","unstructured":"Zeng F, Shi Y, Wu C, Liang J, Zhong Q, Briley K, et al. A drug-free nanozyme for mitigating oxidative stress and inflammatory bowel disease. J Nanobiotechnology. 2022. https:\/\/doi.org\/10.1186\/s12951-022-01319-7.","journal-title":"J Nanobiotechnology"},{"key":"2175_CR60","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.9b05035","author":"Z Miao","year":"2020","unstructured":"Miao Z, Jiang S, Ding M, Sun S, Ma Y, Younis MR, et al. Ultrasmall rhodium nanozyme with RONS scavenging and photothermal activities for anti-inflammation and antitumor theranostics of colon diseases. Nano Lett. 2020. https:\/\/doi.org\/10.1021\/acs.nanolett.9b05035.","journal-title":"Nano Lett"},{"key":"2175_CR61","doi-asserted-by":"publisher","DOI":"10.1021\/acsanm.2c04615","author":"G Wang","year":"2023","unstructured":"Wang G, Qi Y, Xu J, Huang Y, Xiong F, Huang W, et al. Neutrophil membrane-coated mesoporous silica nanoparticles loaded with hydrocortisone alleviate DSS-induced colitis in mice. ACS Appl Nano Mater. 2023. https:\/\/doi.org\/10.1021\/acsanm.2c04615.","journal-title":"ACS Appl Nano Mater"},{"key":"2175_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202403738","author":"Y Jian-Hua","year":"2024","unstructured":"Jian-Hua Y, Chun-Xiao L, Ran-Ran M, Bo-Jia L, Qi-Wen C, Wen L, et al. Sulfasalazine-loaded copper-tannic acid coordination nanozyme enables ROS scavenging and immunomodulation for inflammatory bowel disease therapy. Adv Healthcare Mater. 2024. https:\/\/doi.org\/10.1002\/adhm.202403738.","journal-title":"Adv Healthcare Mater"},{"key":"2175_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1107670","volume":"14","author":"W Jing","year":"2023","unstructured":"Jing W, Liu C, Su C, Liu L, Chen P, Li X, et al. Role of reactive oxygen species and mitochondrial damage in rheumatoid arthritis and targeted drugs. Front Immunol. 2023;14:1107670. https:\/\/doi.org\/10.3389\/fimmu.2023.1107670.","journal-title":"Front Immunol"},{"key":"2175_CR64","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/s0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet (London, England). 2016;388:2023\u201338. https:\/\/doi.org\/10.1016\/s0140-6736(16)30173-8.","journal-title":"Lancet (London, England)"},{"key":"2175_CR65","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review. JAMA. 2018;320:1360\u201372. https:\/\/doi.org\/10.1001\/jama.2018.13103.","journal-title":"JAMA"},{"key":"2175_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.11.072","author":"Z Jucong","year":"2024","unstructured":"Jucong Z, Chenxi W, Xiaochuan W, Qiying S, Yongzhong D. Nanozyme-based therapeutic strategies for rheumatoid arthritis. J Control Release. 2024. https:\/\/doi.org\/10.1016\/j.jconrel.2024.11.072.","journal-title":"J Control Release"},{"key":"2175_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121063","author":"W Li","year":"2021","unstructured":"Li W, Song Y, Liang X, Zhou Y, Xu M, Lu Q, et al. Mutual-reinforcing sonodynamic therapy against rheumatoid arthritis based on sparfloxacin sonosensitizer doped concave-cubic rhodium nanozyme. Biomaterials. 2021. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121063.","journal-title":"Biomaterials"},{"key":"2175_CR68","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c09127","author":"F Zhou","year":"2023","unstructured":"Zhou F, Li M, Chen M, Chen M, Chen X, Luo Z, et al. Redox homeostasis strategy for inflammatory macrophage reprogramming in rheumatoid arthritis based on ceria oxide nanozyme-complexed biopolymeric micelles. ACS Nano. 2023. https:\/\/doi.org\/10.1021\/acsnano.2c09127.","journal-title":"ACS Nano"},{"key":"2175_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2022.02.017","author":"L Zhang","year":"2022","unstructured":"Zhang L, Qin Z, Sun H, Chen X, Dong J, Shen S, et al. Nanoenzyme engineered neutrophil-derived exosomes attenuate joint injury in advanced rheumatoid arthritis via regulating inflammatory environment. Bioact Mater. 2022. https:\/\/doi.org\/10.1016\/j.bioactmat.2022.02.017.","journal-title":"Bioact Mater"},{"key":"2175_CR70","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.2c16458","author":"M Jia","year":"2022","unstructured":"Jia M, Ren W, Liu Y, Wang C, Zheng X, Zhang D, et al. Messenger nanozyme for reprogramming the microenvironment of rheumatoid arthritis. ACS Appl Mater Interfaces. 2022. https:\/\/doi.org\/10.1021\/acsami.2c16458.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2175_CR71","doi-asserted-by":"publisher","DOI":"10.2217\/nnm-2021-0172","author":"P Allawadhi","year":"2022","unstructured":"Allawadhi P, Khurana A, Sayed N, Godugu C, Vohora D. Ameliorative effect of cerium oxide nanoparticles against Freund\u2019s complete adjuvant-induced arthritis. Nanomedicine. 2022. https:\/\/doi.org\/10.2217\/nnm-2021-0172.","journal-title":"Nanomedicine"},{"key":"2175_CR72","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/art.42795","volume":"76","author":"Y Fang","year":"2024","unstructured":"Fang Y, Huang W, Zhu X, Wang X, Wu X, Wang H, et al. Epigenetic regulatory axis MIR22-TET3-MTRNR2L2 represses fibroblast-like synoviocyte-mediated inflammation in rheumatoid arthritis. Arthritis Rheumatol (Hoboken, NJ). 2024;76:845\u201356. https:\/\/doi.org\/10.1002\/art.42795.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"2175_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202400345","author":"Z Xinwei","year":"2025","unstructured":"Xinwei Z, Ziping W, Yu B, Yulun H, Qing C, Yueping L, et al. Therapeutic effect of a near-infrared responsive MTX-Mn3O4@PDA nano-delivery system on rheumatoid arthritis. Adv Therap. 2025. https:\/\/doi.org\/10.1002\/adtp.202400345.","journal-title":"Adv Therap"},{"key":"2175_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2023.146450","author":"M-W Ma","year":"2023","unstructured":"Ma M-W, He K-L, Li C-Q, Xie X-T, Zhou S, Zhang B, et al. Multifunctional platinum-tellurium nanorods modified with hyaluronic acid remove reactive oxygen species to improve the photothermal treatment of rheumatoid arthritis. Chem Eng J. 2023. https:\/\/doi.org\/10.1016\/j.cej.2023.146450.","journal-title":"Chem Eng J"},{"key":"2175_CR75","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.5c04787","author":"M-W Ma","year":"2025","unstructured":"Ma M-W, He K-L, Zhou S, Hu Y-G, Cheng K, Fan J-X, et al. Dual-pronged attack: biomimetic multi-functional MOFs for rheumatoid arthritis therapy via inhibiting synovial hyperplasia and improving immune microenvironment. ACS Nano. 2025. https:\/\/doi.org\/10.1021\/acsnano.5c04787.","journal-title":"ACS Nano"},{"key":"2175_CR76","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323:1945\u201360. https:\/\/doi.org\/10.1001\/jama.2020.4006.","journal-title":"JAMA"},{"key":"2175_CR77","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s246783","author":"L Wu","year":"2020","unstructured":"Wu L, Liu G, Wang W, Liu R, Liao L, Cheng N, et al. Cyclodextrin-modified CeO2 nanoparticles as a multifunctional nanozyme for combinational therapy of psoriasis. Int J Nanomed. 2020. https:\/\/doi.org\/10.2147\/ijn.s246783.","journal-title":"Int J Nanomed"},{"key":"2175_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103055","author":"H Zhao","year":"2024","unstructured":"Zhao H, Zhao H, Li M, Tang Y, Xiao X, Cai Y, et al. Twin defect-rich Pt ultrathin nanowire nanozymes alleviate inflammatory skin diseases by scavenging reactive oxygen species. Redox Biol. 2024. https:\/\/doi.org\/10.1016\/j.redox.2024.103055.","journal-title":"Redox Biol"},{"key":"2175_CR79","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G. Multiple sclerosis - a review. Eur J Neurol. 2019;26:27\u201340. https:\/\/doi.org\/10.1111\/ene.13819.","journal-title":"Eur J Neurol"},{"key":"2175_CR80","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/963520","volume":"2013","author":"A Popa-Wagner","year":"2013","unstructured":"Popa-Wagner A, Mitran S, Sivanesan S, Chang E, Buga AM. ROS and brain diseases: the good, the bad, and the ugly. Oxid Med Cell Longev. 2013;2013:963520. https:\/\/doi.org\/10.1155\/2013\/963520.","journal-title":"Oxid Med Cell Longev"},{"key":"2175_CR81","doi-asserted-by":"publisher","DOI":"10.1021\/nn403743b","author":"KL Heckman","year":"2013","unstructured":"Heckman KL, DeCoteau W, Estevez A, Reed KJ, Costanzo W, Sanford D, et al. Custom cerium oxide nanoparticles protect against a free radical mediated autoimmune degenerative disease in the brain. ACS Nano. 2013. https:\/\/doi.org\/10.1021\/nn403743b.","journal-title":"ACS Nano"},{"key":"2175_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2015.08.008","author":"E Eitan","year":"2015","unstructured":"Eitan E, Hutchison ER, Greig NH, Tweedie D, Celik H, Ghosh S, et al. Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity. Exp Neurol. 2015. https:\/\/doi.org\/10.1016\/j.expneurol.2015.08.008.","journal-title":"Exp Neurol"},{"key":"2175_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2024.114271","author":"LR Abdelalim","year":"2024","unstructured":"Abdelalim LR, Elnaggar YSR, Abdallah OY. Pectin-stabilized nanoceria double coated with lactoferrin\/chitosan for management of experimental autoimmune encephalomyelitis. Colloids Surf B Biointerfaces. 2024. https:\/\/doi.org\/10.1016\/j.colsurfb.2024.114271.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2175_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2025.169965","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Zhou X, Song Y, Tian Q, Li S, Li T, et al. Nanozymes - a new opportunity for the treatment of neurodegenerative diseases. Chem Eng J. 2025. https:\/\/doi.org\/10.1016\/j.cej.2025.169965.","journal-title":"Chem Eng J"},{"key":"2175_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11091659","author":"MF Serra","year":"2022","unstructured":"Serra MF, Cotias AC, Pimentel AS, Arantes ACSd, Pires ALA, Lanzetti M, et al. Gold nanoparticles inhibit steroid-insensitive asthma in mice preserving histone deacetylase 2 and NRF2 pathways. Antioxidants. 2022. https:\/\/doi.org\/10.3390\/antiox11091659.","journal-title":"Antioxidants"},{"key":"2175_CR86","doi-asserted-by":"publisher","first-page":"S575","DOI":"10.1016\/s0091-6749(00)90061-7","volume":"105","author":"P K\u00f6nig","year":"2000","unstructured":"K\u00f6nig P. The effects of cromolyn sodium and nedocromil sodium in early asthma prevention. J Allergy Clin Immunol. 2000;105:S575\u201381. https:\/\/doi.org\/10.1016\/s0091-6749(00)90061-7.","journal-title":"J Allergy Clin Immunol"},{"key":"2175_CR87","doi-asserted-by":"publisher","first-page":"228","DOI":"10.7326\/0003-4819-89-2-228","volume":"89","author":"IL Bernstein","year":"1978","unstructured":"Bernstein IL, Johnson CL. Therapy with cromolyn sodium. Ann Intern Med. 1978;89:228\u201333. https:\/\/doi.org\/10.7326\/0003-4819-89-2-228.","journal-title":"Ann Intern Med"},{"issue":"1","key":"2175_CR88","doi-asserted-by":"publisher","first-page":"665","DOI":"10.4049\/jimmunol.179.1.665","volume":"179","author":"JJ Ryan","year":"2007","unstructured":"Ryan JJ, Bateman HR, Stover A, Gomez G, Norton SK, Zhao W, et al. Fullerene nanomaterials inhibit the allergic response. J Immunol. 2007;179(1):665\u201372. https:\/\/doi.org\/10.4049\/jimmunol.179.1.665.","journal-title":"J Immunol"},{"key":"2175_CR89","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202004115","author":"P Lin","year":"2021","unstructured":"Lin P, Cao M, Xia F, Liao H, Sun H, Wang Q, et al. A phosphatase-mimetic nano-stabilizer of mast cells for long-term prevention of allergic disease. Adv Sci. 2021. https:\/\/doi.org\/10.1002\/advs.202004115.","journal-title":"Adv Sci"},{"key":"2175_CR90","doi-asserted-by":"publisher","DOI":"10.1021\/acsbiomaterials.4c00470","author":"X Xiao","year":"2024","unstructured":"Xiao X, Zhao F, DuBois DB, Liu Q, Zhang YL, Yao Q, et al. Nanozymes for the therapeutic treatment of diabetic foot ulcers. ACS Biomater Sci Eng. 2024. https:\/\/doi.org\/10.1021\/acsbiomaterials.4c00470.","journal-title":"ACS Biomater Sci Eng"},{"key":"2175_CR91","doi-asserted-by":"publisher","DOI":"10.1007\/s12247-023-09774-x","author":"C Rejeeth","year":"2023","unstructured":"Rejeeth C, Varukattu NB, Sharma A, Kumar RS, Almansour AI, Arumugam N. A novel azathioprine polysaccharide nanoparticle enhances the efficacy of systemic lupus erythematosus therapy. J Pharm Innov. 2023. https:\/\/doi.org\/10.1007\/s12247-023-09774-x.","journal-title":"J Pharm Innov"},{"key":"2175_CR92","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c15164","author":"L Junjie","year":"2025","unstructured":"Junjie L, Danqing H, Rui L, Haofang Z, Dandan W, Yuanjin Z, et al. Extracellular matrix-inspired dendrimer nanogels encapsulating cyclophosphamide for systemic sclerosis treatment. ACS Nano. 2025. https:\/\/doi.org\/10.1021\/acsnano.4c15164.","journal-title":"ACS Nano"},{"key":"2175_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2010.05.012","author":"AM Studer","year":"2010","unstructured":"Studer AM, Limbach LK, Van Duc L, Krumeich F, Athanassiou EK, Gerber LC, et al. Nanoparticle cytotoxicity depends on intracellular solubility: comparison of stabilized copper metal and degradable copper oxide nanoparticles. Toxicol Lett. 2010. https:\/\/doi.org\/10.1016\/j.toxlet.2010.05.012.","journal-title":"Toxicol Lett"},{"key":"2175_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2025.07.025","author":"A Li","year":"2025","unstructured":"Li A, Zhu X, Guo Y, Wang Y, Xu Y. Biodegradable enzyme-mimicking nanocatalysts: from degradation behavior to theranostic applications. Acta Biomater. 2025. https:\/\/doi.org\/10.1016\/j.actbio.2025.07.025.","journal-title":"Acta Biomater"},{"key":"2175_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/natrevmats.2016.14","author":"S Wilhelm","year":"2016","unstructured":"Wilhelm S, Tavares AJ, Dai Q, Ohta S, Audet J, Dvorak HF, et al. Analysis of nanoparticle delivery to tumours. Nat Rev Mater. 2016. https:\/\/doi.org\/10.1038\/natrevmats.2016.14.","journal-title":"Nat Rev Mater"},{"key":"2175_CR96","doi-asserted-by":"publisher","DOI":"10.1039\/d5cc04269k","author":"C Guo","year":"2025","unstructured":"Guo C, Zhou Y, Zhang X, Shi J, Zu Y, Qi L, et al. A membrane camouflaged copper single-atom nanozyme for combined mild photothermal and chemodynamic therapy. Chem Commun. 2025. https:\/\/doi.org\/10.1039\/d5cc04269k.","journal-title":"Chem Commun"},{"key":"2175_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/s12645-023-00205-7","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Zhang L, Li Y, Wang J, He X, Zhang J, et al. Targeting and sensitizing MDR cancer by an MMP2 and pH dual-responsive ZnO-based nanomedicine. Cancer Nanotechnol. 2023. https:\/\/doi.org\/10.1186\/s12645-023-00205-7.","journal-title":"Cancer Nanotechnol"},{"key":"2175_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121133","author":"YH Dinakar","year":"2022","unstructured":"Dinakar YH, Karole A, Parvez S, Jain V, Mudavath SL. Organ-restricted delivery through stimuli-responsive nanocarriers for lung cancer therapy. Life Sci. 2022. https:\/\/doi.org\/10.1016\/j.lfs.2022.121133.","journal-title":"Life Sci"},{"key":"2175_CR99","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","volume":"99","author":"JS Suk","year":"2016","unstructured":"Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99:28\u201351. https:\/\/doi.org\/10.1016\/j.addr.2015.09.012.","journal-title":"Adv Drug Deliv Rev"},{"key":"2175_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-96815-9","author":"W Xuan","year":"2025","unstructured":"Xuan W, Li X, Gao H, Zhang L, Hu J, Sun L, et al. Artificial intelligence driven platform for rapid catalytic performance assessment of nanozymes. Sci Rep. 2025. https:\/\/doi.org\/10.1038\/s41598-025-96815-9.","journal-title":"Sci Rep"},{"key":"2175_CR101","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1982","author":"T Li","year":"2024","unstructured":"Li T, Wang Y, Zhou D. Manipulation of protein corona for nanomedicines. WIREs Nanomed Nanobiotechnol. 2024. https:\/\/doi.org\/10.1002\/wnan.1982.","journal-title":"WIREs Nanomed Nanobiotechnol"},{"key":"2175_CR102","doi-asserted-by":"publisher","DOI":"10.1039\/d1tb01063h","author":"M Yang","year":"2021","unstructured":"Yang M, Wu E, Tang W, Qian J, Zhan C. Interplay between nanomedicine and protein corona. J Mater Chem B. 2021. https:\/\/doi.org\/10.1039\/d1tb01063h.","journal-title":"J Mater Chem B"},{"key":"2175_CR103","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201805740","author":"R Cai","year":"2018","unstructured":"Cai R, Chen C. The crown and the scepter: roles of the protein corona in nanomedicine. Adv Mater. 2018. https:\/\/doi.org\/10.1002\/adma.201805740.","journal-title":"Adv Mater"},{"key":"2175_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2023.103010","volume":"84","author":"TT Tran","year":"2023","unstructured":"Tran TT, Roffler SR. Interactions between nanoparticle corona proteins and the immune system. Curr Opin Biotechnol. 2023;84:103010. https:\/\/doi.org\/10.1016\/j.copbio.2023.103010.","journal-title":"Curr Opin Biotechnol"},{"key":"2175_CR105","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202304123","author":"R Chen","year":"2023","unstructured":"Chen R, Yang J, Wu M, Zhao D, Yuan Z, Zeng L, et al. M2 macrophage hybrid membrane-camouflaged targeted biomimetic nanosomes to reprogram inflammatory microenvironment for enhanced enzyme-thermo-immunotherapy. Adv Mater. 2023. https:\/\/doi.org\/10.1002\/adma.202304123.","journal-title":"Adv Mater"},{"key":"2175_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-024-01715-0","author":"J Xu","year":"2024","unstructured":"Xu J, Wu M, Yang J, Zhao D, He D, Liu Y, et al. Multimodal smart systems reprogramme macrophages and remove urate to treat gouty arthritis. Nat Nanotechnol. 2024. https:\/\/doi.org\/10.1038\/s41565-024-01715-0.","journal-title":"Nat Nanotechnol"},{"key":"2175_CR107","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.4c04345","author":"L Guo","year":"2024","unstructured":"Guo L, Yan H, Gong Q, Zheng W, Zhong L, Gong T, et al. Glomerulus-targeted ROS-responsive polymeric nanoparticles for effective membranous nephropathy therapy. ACS Appl Mater Interfaces. 2024. https:\/\/doi.org\/10.1021\/acsami.4c04345.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2175_CR108","doi-asserted-by":"publisher","DOI":"10.1002\/mabi.20220028","author":"OT Shofolawe-Bakare","year":"2022","unstructured":"Shofolawe-Bakare OT, de Mel JU, Mishra SK, Hossain M, Hamadani CM, Pride MC, et al. ROS-responsive glycopolymeric nanoparticles for enhanced drug delivery to macrophages. Macromol Biosci. 2022. https:\/\/doi.org\/10.1002\/mabi.20220028.","journal-title":"Macromol Biosci"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02175-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02175-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02175-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:13:17Z","timestamp":1769523197000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02175-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2175"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02175-5","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"14 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"This study did not involve human participants or animals, and therefore no ethical approval was required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"All authors have reviewed and approved the final version of the manuscript and consent to its publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"23"}}